Serge - Pharma Boardroom

This is the first time PharmaBoardroom has had the opportunity to sit down with Nipro

Can you introduce our readers to the company, its mission, and its major operations?

Nipro is a leading healthcare organisation based in Osaka, Japan. It was founded in 1954 and is truly focused on care. Represented by the infinity sign in our logo, Nipro’s continuous commitment is more than a symbol. We demonstrate this in all that we do; our current and future responsibility to society is to develop innovative healthcare technologies that help patients worldwide.

We have three main divisions: medical devices, pharma, and pharma packaging. Our largest business segment is medical devices. Within medical devices, 70 to 80 percent of the business is composed of dialysis, a therapeutic area in which we are a top-three player globally.

The pharma division mainly produces generic drugs or is a contract manufacturer to larger pharmaceutical companies. In fact, Nipro is the largest contract manufacturer in Japan. The majority of our clients are active in Japan, either Japanese companies or Western companies distributing there.

The Pharma Packaging division is a global supplier of primary packaging material (a.o. glass vials, syringes, cartridges, …) to pharmaceutical companies.

Read further at